Tissue and Plasma Biomarkers of Lymph Node Involvement in Cervical Cancer

Not Recruiting

Trial ID: NCT01546363

Purpose

The purpose of this study is to measure the levels of serum proteins and other biomarkers in cervical cancer patients. We believe that some of these markers may be useful in selecting patients for specific types of cancer therapies. These markers may also help to predict response to therapy, relapse after therapy, and survival after therapy.

Official Title

Tissue and Plasma Biomarkers of Lymph Node Involvement in Cervical Cancer

Stanford Investigator(s)

Elizabeth Kidd
Elizabeth Kidd

Associate Professor of Radiation Oncology (Radiation Therapy)

Jonathan S. Berek, MD, MMSc
Jonathan S. Berek, MD, MMSc

Laurie Kraus Lacob Professor

Eligibility

Inclusion Criteria:

* Patients must have a known or suspected cervical cancer.
* Age \>=18 years.
* Patients must have no other active cancer at the time of diagnosis.
* Patients must have no history of a hysterectomy.
* Patients must be able to give informed consent.
* Patients must be willing to undergo a biopsy of the cervical tumor to provide tissue for the study.
* Patients must have completed a standard-of-care FDG-PET/CT prior to initiation of therapy, for assessment of lymph nodes.

Exclusion Criteria:

- Pregnant women

Intervention(s):

other: Blood draw

Not Recruiting

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Dylann Fujimoto
650-723-8843

New Trial Alerts